Brigham and Women’s Faulkner Hospital Names Douglas Smink, MD, MPH, New Chief of Surgery

Douglas Smink, MD, MPH

Brigham and Women’s Faulkner Hospital has named Douglas Smink, MD, MPH, as its new Chief of Surgery, effective January 1, 2020.  Dr. Smink currently serves as the Associate Chair of Education in the Department of Surgery at Brigham and Women’s Hospital and Program Director of the General Surgery Residency.

Dr. Smink received his medical degree from the University of Pennsylvania School of Medicine, completed General Surgery Residency at BWH and a Minimally Invasive Surgery Fellowship at Dartmouth-Hitchcock Medical Center.  His clinical interests include abdominal wall hernias, foregut surgery, and biliary tract disease. 

“We are thrilled to have Dr. Smink join our team,” says David O. McCready, President of Brigham and Women’s Faulkner Hospital.  “We believe that he is an incredibly talented physician who has the right mix of education and experience to lead our surgical staff for years to come.”

Dr. Smink also serves as the editor-in-chief of the Journal of Surgical Education and was recently selected by the American College of Surgeons to the Academy of Master Surgeon Educators.

His research focuses on resident and faculty education and how to teach communication, leadership and decision-making to surgeons and surgical teams. He is the co-leader of the Surgical Culture Program at the BWH Center for Surgery and Public Health (CSPH) and a co-PI on the NIH R01 Provider Awareness Cultural Dexterity Toolkit for Surgeons (PACTS) grant.  He is also the co-director of the Surgical Coaching for Operative Performance Enhancement (SCOPE) Program at Ariadne Labs. 

Dr. Smink succeeds Dr. Pardon Kenney, who has served as Chief of Surgery at BWFH for more than 30 years.

Chandrajit P. Raut, MD, MS, Named Chief of Surgical Oncology at Brigham Health

After an extensive national search, Chandrajit P. Raut, MD, MS, has been named division chief of Surgical Oncology at Brigham Health, effective October 1, 2019.

Dr. Raut, who is also a professor of surgery at Harvard Medical School and surgery director of the Center for Sarcoma and Bone Oncology at Dana-Farber Cancer Institute, is a graduate of Stanford University (BA/BS), University of Oxford (MSc) and Harvard Medical School (MD). He completed a general surgery residency at Massachusetts General Hospital followed by a surgical oncology fellowship at MD Anderson Cancer Center. 

Dr. Raut is a committed clinician who specializes in the multidisciplinary care of patients with soft tissue sarcoma. He is also a prolific researcher, and currently has a multi-PI R01 grant to evaluate an innovative drug-eluting film to be placed in the surgical bed to reduce tumor local recurrence rates. Additionally, he is co-PI on a multi-institutional phase II clinical trial evaluating five years of adjuvant imatinib for primary GIST, co-investigator on an international phase III randomized clinical trial evaluating the use of preoperative radiation therapy for retroperitoneal sarcomas, and a member of The Cancer Genome Atlas Sarcoma (TCGA-SARC) working group of the National Institutes of Health (NIH)/National Cancer Institute (NCI). 

Dr. Raut serves as section editor for sarcoma in the journals Cancer and Annals of Surgical Oncology, associate editor for the journal Sarcoma and an editorial board member for the journal ACS Case Reports in Surgery. He has authored over 200 papers and over 30 book chapters and also serves as the program director of the Dana-Farber/Partners Cancer Care Surgical Oncology Fellowship.